Enzoheal 2% Ointment contains Mupirocin 2% w/w, a topical antibiotic effective against a variety of gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It is primarily indicated for the treatment of superficial skin infections such as impetigo, folliculitis, and infected eczema. Mupirocin acts by inhibiting bacterial isoleucyl-tRNA synthetase, thereby preventing protein synthesis and bacterial replication. Enzoheal 2% Ointment is applied topically to the affected area two to three times daily, typically for a duration of 5 to 10 days, depending on clinical response. It is important to clean and dry the affected area before application. The ointment is generally well tolerated; however, local adverse reactions such as burning, stinging, or itching may occur. Systemic absorption is minimal, reducing the risk of systemic side effects. Use of Enzoheal 2% Ointment should be avoided in patients with known hypersensitivity to mupirocin or any excipients in the formulation. Caution is advised when applying near the eyes or mucous membranes. Proper adherence to the prescribed regimen is essential to prevent bacterial resistance and ensure optimal therapeutic outcomes.